Marc Edwards

Marc Edwards is a declared insider of Kane Biotech Inc., with filings sourced from SEDI. Over a trading history stretching from 2 June 2016 to 17 January 2025, the count stands at 18 filings.

No open-market sale appears; the market trades are 15 purchases worth €299k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €9,459. The 15 purchases reviewed show no overlap with other insiders buying the same stock within a month.

On 23 January 2025 came the latest disclosure, an open-market purchase for €135k in Kane Biotech Inc. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.